Janssen Pharma (JNJ) Plans to Gain FDA Approval for 10 New Products by 2019

Go back to Janssen Pharma (JNJ) Plans to Gain FDA Approval for 10 New Products by 2019
Johnson & Johnson (NYSE: JNJ) Delayed: 168.50 +0.76 (0.45%)
Previous Close $167.74    52 Week High $126.07 
Open $168.30    52 Week Low $94.28 
Day High $169.18    P/E 35.03 
Day Low $167.83    EPS $4.81 
Volume 5,317,104